The '90s are alive and well in a British laboratory.
Researchers in the U.K. have found that relatives of Dolly, who became famous in 1996 as the first mammal to be cloned, are healthy even into old age, allaying fears among some that genetic copies may begin to suffer ailments associated with aging sooner than their naturally bred counterparts.
Created in Edinburgh, Scotland, Dolly died in 2003 at just over 6 years old. The average lifespan of a sheep is about 10 years, and Dolly had been undergoing treatment for arthritis and lung disease. Her early death led some to speculate that the cloning process could cause health issues well into adulthood.
But that doesn’t seem to be the case, according to a study written by the researchers and published July 26 in the journal Nature Communications.
Scientists examined blood sugar levels, blood pressure, and muscular and joint health of 13 cloned sheep. Four of those came from the same batch of DNA as Dolly and were created between 2005 and 2007 using somatic-cell nuclear transfer (SCNT), the same procedure used in 1996.
“We could find no evidence, therefore, of a detrimental long-term effect of cloning by SCNT on the health of aged offspring among our cohort,” the researchers said.
The study is first to examine the health of cloned animals at such an advanced age relative to their species. Researchers said that though animals who survive into adulthood showed no signs of cloning-related health issues, a high proportion of embryo’s fail to make it to term.
When news first broke that scientists had cloned Dolly, the public had mixed reactions. Some hailed it as a major step in medicine and agriculture; others said it was a slippery slope to human cloning. In 2003, the Food and Drug Administration said that cloned animals were safe for human consumption, but the use of cloned animals for meat never caught on.
Dolly was the subject of a U.S. court case over whether the Roslin Institute at the University of Edinburgh, which performed the cloning procedure, could patent the sheep. In 2014, the U.S. Court of Appeals for the Federal Circuit rejected the patent application, finding that the requirement for “markedly different characteristics” in an organism can’t be met when the invention claimed—in this case Dolly—is identical to the donor animal.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)